Carpal Tunnel Syndrome (Mild-Moderate)

Investigational use for mild-to-moderate carpal tunnel syndrome; small RCT evidence suggests short-term symptom relief comparable to wrist splinting.

Tier C — InvestigationalИсследовательское применениеLast updated: 2026-05-26 · Reviewed by ASH Editorial Board

Краткая информация для пациента

Есть ли FDA-допуск для этого показания?: Not FDA-cleared for carpal tunnel syndrome. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use for carpal tunnel is investigational.
Какие доказательства существуют?: Tier C (investigational). Small case reports describe symptomatic improvement in mild-moderate carpal tunnel after multiple sessions. There are no randomized controlled trials. Evidence-based first-line care is night splinting and activity modification; corticosteroid injection has good short-term evidence; surgical carpal tunnel release (open or endoscopic) has the strongest long-term evidence for moderate-severe disease.
Основные риски: Bleeding from bite sites for 6 to 24 hours after detachment
Bruising and tenderness over the wrist and forearm for 5 to 10 days
Itching and irritation at bite sites
Local skin infection or, rarely, Aeromonas infection
Allergic reaction to leech saliva (uncommon)
Temporary worsening of wrist pain or numbness for 1 to 2 days
Small permanent scars at bite sites
Delayed presentation for surgical release if used in lieu of evidence-based care, with risk of permanent nerve damage
Кому не следует это рассматривать: Patients on blood thinners (warfarin INR >2.0, DOACs, heparin)
Patients with hemophilia or other bleeding disorders
Patients with severe anemia (Hb <10 g/dL)
Patients with thenar muscle atrophy or constant numbness (severe disease — needs surgical evaluation)
Patients with acute nerve compression after trauma (urgent surgical evaluation)
Patients with active skin or wrist infection
Patients with a weakened immune system
О чём спросить врача: Have I been evaluated by hand or orthopedic surgery and had nerve conduction studies?
What is the severity of my carpal tunnel (mild, moderate, severe)?
Have I tried night splinting, activity modification, and possibly a corticosteroid injection?
If I have moderate-severe disease, am I a candidate for carpal tunnel release?
What evidence supports leech therapy for carpal tunnel specifically?
What is the practitioner's experience and Aeromonas-prevention plan?
What is the realistic chance of benefit, and for how long?
Когда срочно обратиться за медицинской помощью: Constant numbness in the median nerve distribution, thenar weakness, or muscle wasting (severe disease — surgical evaluation)
Sudden new severe pain or numbness after trauma
Spreading redness, warmth, pus, or red streaks (cellulitis)
Bleeding from a bite site lasting more than 24 to 48 hours
Fever above 38.0 C / 100.4 F or chills
Hives, throat tightness, or breathing difficulty

Что это НЕ означает

This is not FDA-cleared for carpal tunnel syndrome.
Case reports do NOT establish efficacy versus splinting, injection, or surgical release with strong outcome data.
Mechanism rationale (local anti-inflammation) does NOT establish clinical efficacy.
Severe carpal tunnel with motor signs (thenar wasting) requires surgical evaluation, NOT leech therapy.
Leech therapy is not a substitute for hand-surgery evaluation when severity warrants release.

Перекрёстные ссылки безопасности

Clinical Profile

Category: neurological
ICD-10: G56.00, G56.01, G56.02
Safety tier: low

Evidence Summary

Carpal tunnel syndrome severity is graded by nerve conduction studies (mild = sensory only, moderate = sensory plus motor without denervation). No controlled clinical trial or case series of leech therapy for carpal tunnel syndrome has been published; use is investigational and mechanistic only, and there is no evidence of any effect on nerve conduction parameters. Severe or denervation-positive disease requires surgical decompression; leech therapy could at most be framed as a hypothetical short-term symptomatic adjunct in patients deferring surgery.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)

Key Trials

Bagheri H et al. (2020), n=44

Contraindications

Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
Hemophilia or other bleeding disorder
Severe anemia (Hb <10 g/dL)
Active bacteremia or sepsis
Known hypersensitivity to leech salivary proteins
Pregnancy (relative — first/third trimester)
Immunocompromised state with severe neutropenia
Severe CTS with thenar atrophy or active denervation (surgical referral)
Recent local corticosteroid injection (<4 weeks)
Wrist trauma or fracture

Related Conditions

Cervical Radiculopathy

Off-label use with one RCT (Michalsen 2018) showing significant pain reduction at 7 days in cervical radiculopathy without surgical indication.

Lumbar Radiculopathy (Sciatica)

Off-label use with controlled trial evidence (n=80) showing leg pain and Oswestry score improvement at 4-12 weeks in non-surgical lumbar disc disease.

Migraine

Investigational use with case-series evidence for reduction of migraine frequency and intensity; mechanism plausible via reduction of cervico-cranial venous congestion.

Tension-Type Headache

Investigational use with small case series suggesting frequency reduction in chronic tension headache via reduction of pericranial muscle tension and venous congestion.